BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

254 related articles for article (PubMed ID: 18298442)

  • 1. Fascin expression [corrected] in glial tumors and its prognostic significance in glioblastomas.
    Gunal A; Onguru O; Safali M; Beyzadeoglu M
    Neuropathology; 2008 Aug; 28(4):382-6. PubMed ID: 18298442
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fascin expression in 90 patients with glioblastoma multiforme.
    Roma AA; Prayson RA
    Ann Diagn Pathol; 2005 Dec; 9(6):307-11. PubMed ID: 16308158
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fascin overexpression is involved in carcinogenesis and prognosis of human intrahepatic cholangiocarcinoma: immunohistochemical and molecular analysis.
    Iguchi T; Aishima S; Taketomi A; Nishihara Y; Fujita N; Sanefuji K; Sugimachi K; Yamashita Y; Maehara Y; Tsuneyoshi M
    Hum Pathol; 2009 Feb; 40(2):174-80. PubMed ID: 18835624
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prognostic significance of fascin expression in extrahepatic bile duct carcinomas.
    Won KY; Kim GY; Lim SJ; Park YK; Kim YW
    Pathol Res Pract; 2009; 205(11):742-8. PubMed ID: 19556073
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pitfalls in the assessment of MGMT expression and in its correlation with survival in diffuse astrocytomas: proposal of a feasible immunohistochemical approach.
    Capper D; Mittelbronn M; Meyermann R; Schittenhelm J
    Acta Neuropathol; 2008 Feb; 115(2):249-59. PubMed ID: 17965865
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunohistochemical analysis of metallothionein in astrocytic tumors in relation to tumor grade, proliferative potential, and survival.
    Hiura T; Khalid H; Yamashita H; Tokunaga Y; Yasunaga A; Shibata S
    Cancer; 1998 Dec; 83(11):2361-9. PubMed ID: 9840536
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Grade-specific expression of insulin-like growth factor-binding proteins-2, -3, and -5 in astrocytomas: IGFBP-3 emerges as a strong predictor of survival in patients with newly diagnosed glioblastoma.
    Santosh V; Arivazhagan A; Sreekanthreddy P; Srinivasan H; Thota B; Srividya MR; Vrinda M; Sridevi S; Shailaja BC; Samuel C; Prasanna KV; Thennarasu K; Balasubramaniam A; Chandramouli BA; Hegde AS; Somasundaram K; Kondaiah P; Rao MR
    Cancer Epidemiol Biomarkers Prev; 2010 Jun; 19(6):1399-408. PubMed ID: 20501753
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fascin overexpression correlates with positive thrombospondin-1 and syndecan-1 expressions and a more aggressive clinical course in patients with gallbladder cancer.
    Roh YH; Kim YH; Choi HJ; Lee KE; Roh MS
    J Hepatobiliary Pancreat Surg; 2009; 16(3):315-21. PubMed ID: 19259612
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Geminin: a good prognostic factor in high-grade astrocytic brain tumors.
    Shrestha P; Saito T; Hama S; Arifin MT; Kajiwara Y; Yamasaki F; Hidaka T; Sugiyama K; Kurisu K
    Cancer; 2007 Mar; 109(5):949-56. PubMed ID: 17262828
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cyclooxygenase-2 expression in human gliomas: prognostic significance and molecular correlations.
    Shono T; Tofilon PJ; Bruner JM; Owolabi O; Lang FF
    Cancer Res; 2001 Jun; 61(11):4375-81. PubMed ID: 11389063
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tenascin-C expression relates to clinicopathological features in pilocytic and diffuse astrocytomas.
    Maris C; Rorive S; Sandras F; D'Haene N; Sadeghi N; Bièche I; Vidaud M; Decaestecker C; Salmon I
    Neuropathol Appl Neurobiol; 2008 Jun; 34(3):316-29. PubMed ID: 17983425
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Biologic significance of fascin expression in clear cell renal cell carcinoma: systematic analysis of primary and metastatic tumor tissues using a tissue microarray technique.
    Zigeuner R; Droschl N; Tauber V; Rehak P; Langner C
    Urology; 2006 Sep; 68(3):518-22. PubMed ID: 16979727
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fascin expression in serous tumors of ovary correlates with aggressiveness of malignancy.
    Wen YH; Yee H; Goswami S; Shukla PS
    Int J Gynecol Pathol; 2009 Mar; 28(2):187-92. PubMed ID: 19188814
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prognostic significance of fascin expression in advanced poorly differentiated serous ovarian cancer.
    Daponte A; Kostopoulou E; Papandreou CN; Daliani DD; Minas M; Koukoulis G; Messinis IE
    Anticancer Res; 2008; 28(3B):1905-10. PubMed ID: 18630479
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Secreted protein, acidic and rich in cysteine (SPARC) expression in astrocytic tumour cells negatively correlates with proliferation, while vascular SPARC expression is associated with patient survival.
    Capper D; Mittelbronn M; Goeppert B; Meyermann R; Schittenhelm J
    Neuropathol Appl Neurobiol; 2010 Apr; 36(3):183-97. PubMed ID: 20132490
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prognostic significance of fascin expression in advanced colorectal cancer: an immunohistochemical study of colorectal adenomas and adenocarcinomas.
    Hashimoto Y; Skacel M; Lavery IC; Mukherjee AL; Casey G; Adams JC
    BMC Cancer; 2006 Oct; 6():241. PubMed ID: 17029629
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Expression of fascin and cytokeratin 14 in esophageal squamous cell carcinoma].
    Xue LY; Song YM; Tong T; Luo W; Dong LJ; Zou SM; Zheng S; Bi R; Zhan QM; Lü N
    Zhonghua Yi Xue Za Zhi; 2007 Sep; 87(35):2494-8. PubMed ID: 18067814
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Minichromosome maintenance protein 3 elicits a cancer-restricted immune response in patients with brain malignancies and is a strong independent predictor of survival in patients with anaplastic astrocytoma.
    Söling A; Sackewitz M; Volkmar M; Schaarschmidt D; Jacob R; Holzhausen HJ; Rainov NG
    Clin Cancer Res; 2005 Jan; 11(1):249-58. PubMed ID: 15671553
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cyclooxygenase-2 (Cox-2) expression and angiogenesis in glioblastoma.
    Onguru O; Gamsizkan M; Ulutin C; Gunhan O
    Neuropathology; 2008 Feb; 28(1):29-34. PubMed ID: 18181832
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The glucose transporter and blood-brain barrier of human brain tumors.
    Guerin C; Laterra J; Hruban RH; Brem H; Drewes LR; Goldstein GW
    Ann Neurol; 1990 Dec; 28(6):758-65. PubMed ID: 2178329
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.